Swiss National Bank’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $862K | Buy |
501,156
+87,800
| +21% | +$151K | ﹤0.01% | 2188 |
|
|
2025
Q1 | $1.38M | Sell |
413,356
-4,500
| -1% | -$15K | ﹤0.01% | 1976 |
|
|
2024
Q4 | $3.09M | Buy |
417,856
+35,500
| +9% | +$263K | ﹤0.01% | 1591 |
|
|
2024
Q3 | $3.59M | Sell |
382,356
-2,100
| -0.5% | -$19.7K | ﹤0.01% | 1515 |
|
|
2024
Q2 | $3.08M | Buy |
384,456
+5,500
| +1% | +$44.1K | ﹤0.01% | 1573 |
|
|
2024
Q1 | $5.62M | Sell |
378,956
-60,500
| -14% | -$897K | ﹤0.01% | 1229 |
|
|
2023
Q4 | $3.57M | Sell |
439,456
-49,900
| -10% | -$406K | ﹤0.01% | 1491 |
|
|
2023
Q3 | $2.23M | Buy |
489,356
+77,700
| +19% | +$354K | ﹤0.01% | 1767 |
|
|
2023
Q2 | $2.9M | Buy |
411,656
+156,100
| +61% | +$1.1M | ﹤0.01% | 1650 |
|
|
2023
Q1 | $1.56M | Sell |
255,556
-30,200
| -11% | -$185K | ﹤0.01% | 1993 |
|
|
2022
Q4 | $1.83M | Buy |
285,756
+6,200
| +2% | +$39.6K | ﹤0.01% | 1950 |
|
|
2022
Q3 | $2.68M | Buy |
279,556
+2,000
| +0.7% | +$19.2K | ﹤0.01% | 1672 |
|
|
2022
Q2 | $3.06M | Sell |
277,556
-19,200
| -6% | -$212K | ﹤0.01% | 1625 |
|
|
2022
Q1 | $4.94M | Buy |
296,756
+23,900
| +9% | +$398K | ﹤0.01% | 1440 |
|
|
2021
Q4 | $5.21M | Buy |
272,856
+2,700
| +1% | +$51.5K | ﹤0.01% | 1438 |
|
|
2021
Q3 | $6.66M | Buy |
270,156
+11,000
| +4% | +$271K | ﹤0.01% | 1255 |
|
|
2021
Q2 | $6.74M | Buy |
259,156
+7,800
| +3% | +$203K | ﹤0.01% | 1274 |
|
|
2021
Q1 | $7.96M | Buy |
251,356
+3,000
| +1% | +$95K | 0.01% | 1140 |
|
|
2020
Q4 | $11.5M | Buy |
248,356
+4,500
| +2% | +$209K | 0.01% | 857 |
|
|
2020
Q3 | $8.03M | Buy |
243,856
+3,700
| +2% | +$122K | 0.01% | 910 |
|
|
2020
Q2 | $6.59M | Buy |
240,156
+32,156
| +15% | +$883K | 0.01% | 990 |
|
|
2020
Q1 | $6.23M | Buy |
208,000
+6,500
| +3% | +$195K | 0.01% | 820 |
|
|
2019
Q4 | $5.58M | Buy |
201,500
+4,400
| +2% | +$122K | 0.01% | 1075 |
|
|
2019
Q3 | $3.59M | Buy |
197,100
+1,900
| +1% | +$34.6K | ﹤0.01% | 1299 |
|
|
2019
Q2 | $4.79M | Buy |
195,200
+4,400
| +2% | +$108K | 0.01% | 1155 |
|
|
2019
Q1 | $1.82M | Buy |
190,800
+14,100
| +8% | +$134K | ﹤0.01% | 1721 |
|
|
2018
Q4 | $1.56M | Buy |
176,700
+53,100
| +43% | +$470K | ﹤0.01% | 1728 |
|
|
2018
Q3 | $1.39M | Hold |
123,600
| – | – | ﹤0.01% | 1954 |
|
|
2018
Q2 | $1.58M | Hold |
123,600
| – | – | ﹤0.01% | 1861 |
|
|
2018
Q1 | $2.09M | Buy |
123,600
+19,000
| +18% | +$321K | ﹤0.01% | 1606 |
|
|
2017
Q4 | $837K | Hold |
104,600
| – | – | ﹤0.01% | 2186 |
|
|
2017
Q3 | $811K | Buy |
104,600
+15,500
| +17% | +$120K | ﹤0.01% | 2189 |
|
|
2017
Q2 | $655K | Buy |
89,100
+14,500
| +19% | +$107K | ﹤0.01% | 2311 |
|
|
2017
Q1 | $556K | Hold |
74,600
| – | – | ﹤0.01% | 2342 |
|
|
2016
Q4 | $518K | Hold |
74,600
| – | – | ﹤0.01% | 2378 |
|
|
2016
Q3 | $614K | Hold |
74,600
| – | – | ﹤0.01% | 2249 |
|
|
2016
Q2 | $604K | Hold |
74,600
| – | – | ﹤0.01% | 2249 |
|
|
2016
Q1 | $367K | Buy |
74,600
+13,000
| +21% | +$64K | ﹤0.01% | 2427 |
|
|
2015
Q4 | $476K | Buy |
61,600
+23,800
| +63% | +$184K | ﹤0.01% | 2289 |
|
|
2015
Q3 | $218K | Buy |
37,800
+6,100
| +19% | +$35.2K | ﹤0.01% | 2477 |
|
|
2015
Q2 | $291K | Buy |
+31,700
| New | +$291K | ﹤0.01% | 2460 |
|